About Rgeno Pharmaceuticals Private Limited
Data last updated:
Rgeno Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC304439. Its GSTIN is 10AAICR7324R1Z0 (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Dilip Kumar and Deepak Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – 14 Ganesham Chs. Ltd. Plot No B/1 – 8 Sector 19 Koparkhairane, Navi Mumbai, Maharashtra, India – 400709.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.62 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net profit of ₹5,545 (net margin 3.4%) and EBITDA of ₹9,843 (EBITDA margin 6.1%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 30% over five years.
The company is associated with 1 brand: Rgeno Pharmaceuticals.
For more details, the company can be reached via its website rgenopharma.com.
Company details
Contact details
Rgeno Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is rgenopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No – 14 Ganesham Chs. Ltd. Plot No B/1 – 8 Sector 19 Koparkhairane, Navi Mumbai, Maharashtra, India – 400709
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rgeno Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Rgeno Pharmaceuticals operates one associated brand: Rgeno Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and supplying pharmaceutical products in India. | rgenopharma.com |
Business activity
The main business activity of Rgeno Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rgeno Pharmaceuticals Private Limited, buy the company report.
Financials of Rgeno Pharmaceuticals Private Limited
FY 2025 filings availableRgeno Pharmaceuticals Private Limited reported revenue of ₹1.62 Lakh (down 41% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 41% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 30%. EBITDA rose 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9,843 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,545 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.1% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rgeno Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rgeno Pharmaceuticals Private Limited
Rgeno Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dilip Kumar | Director | 18 Jan 2018 | 8 Years 9 Months | Current |
| Deepak Kumar | Director | 18 Jan 2018 | 8 Years 9 Months | Current |
Auditor
Rgeno Pharmaceuticals Private Limited is audited by C. S. P. & ASSOCIATES LLP for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C. S. P. & ASSOCIATES LLP | FY 2020 | 015849C/C400018 |
Shareholding
The shareholding of Rgeno Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Rgeno Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rgeno Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rgeno Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rgeno Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAICR7324R1Z0 | Bihar | Active | 19 Dec 2018 |
To see the full GST registrations and return filing status of Rgeno Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rgeno Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Deepak Kumar was appointed as Director on 18 Jan 2018.
Frequently asked questions
Rgeno Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 2018 (8+ years old) and is registered under CIN U74999MH2018PTC304439.
Rgeno Pharmaceuticals has 2 current directors:
- Dilip Kumar - Director
- Deepak Kumar - Director
The latest financial statements of Rgeno Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Rgeno Pharmaceuticals is 10AAICR7324R1Z0, registered in Bihar.
The CIN (Corporate Identification Number) of Rgeno Pharmaceuticals is U74999MH2018PTC304439. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rgeno Pharmaceuticals was incorporated on 18 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Deepak Kumar was appointed as Director on 18 Jan 2018. Dilip Kumar was appointed as Director on 18 Jan 2018.
Rgeno Pharmaceuticals can be reached through the website rgenopharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Rgeno Pharmaceuticals is at Shop No – 14 Ganesham Chs. Ltd. Plot No B1 – 8 Sector 19 Koparkhairane, Navi Mumbai, Maharashtra, India – 400709.
Rgeno Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
